Dragonfly Therapeutics

Dragonfly Therapeutics Overview

Founded 2015
Founded
Status Private
Employees 10
Employees
Latest Deal Type Early Stage VC
Investors 5

Dragonfly Therapeutics General Information

Description

Developer of a cancer therapies created to stimulate the body's immune system against cancer. The company's therapy enhances immunotherapy using natural killer cells and counterbalances immune suppressive factors present in the tumor microenvironment and mobilizes anti-cancer immune responses, enabling oncologists to identify the early symptoms of cancer and thus initiate treatment quickly.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • 35 Gatehouse Drive
  • Waltham, MA 02451
  • United States
+1 (617) 000-0000

Dragonfly Therapeutics Timeline

2017201820192020
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Dragonfly Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC 19-Mar-2020 0000 Completed Generating Revenue
3. Corporate 15-May-2017 0000 0000 Completed Generating Revenue
2. Accelerator/Incubator 17-May-2016 Completed Generating Revenue
1. Angel (individual) 01-Jan-2016 Completed Generating Revenue

Dragonfly Therapeutics Executive Team (4)

Name Title Board Seat Contact Info
William Haney Co-Founder & Chief Executive Officer
Tapan Maniar Senior Vice President & Head of Clinical Development
David Raulet Ph.D Co-Founder & Member of Scientific Advisory Board
Tyler Jacks Ph.D Co-Founder & Member of Scientific Advisory Board

Dragonfly Therapeutics Board Members (2)

Name Representing Role Since
David Raulet Ph.D Self Co-Founder & Member of Scientific Advisory Board 000 0000
Tyler Jacks Ph.D Self Co-Founder & Member of Scientific Advisory Board 000 0000

Dragonfly Therapeutics Investors (5)

To view Dragonfly Therapeutics‘s full investor history, request access »
Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Agent Capital Venture Capital Minority 000 0000 000000 0
Fidelity Management & Research Asset Manager Minority 000 0000 000000 0
Celgene Corporation Minority 000 0000 000000 0
JLABS Accelerator/Incubator Minority 000 0000 000000 0
Carica Investments Other Minority 000 0000 000000 0

Ready to get started?

Request a free trial